1. Villoria, JG, Pajares, S, López, RM, et al. Neonatal screening for inherited metabolic diseases in 2016. Semin Pediatr Neurol 2016; 23: 257–272.
Google Scholar | Crossref | Medline2. Xuefan, G. Clinical genetic metabolic diseases. Beijing, China: People’s Health Publishing House, 2015, pp.80–84.
Google Scholar3. Chace, DH, Kalas, TA, Naylor, EW. Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns. Clin Chem 2003; 49: 1797–1817.
Google Scholar | Crossref | Medline | ISI4. Zhao, ZY. Progress of neonatal genetic metabolic disease screening. Chin J Pract Pediatr 2014; 29: 586–589.
Google Scholar5. Khneisser, I, Adib, S, Assaad, S, et al. Cost-benefit analysis: newborn screening for inborn errors of metabolism in Lebanon. J Med Screen 2015; 22: 182–186.
Google Scholar | SAGE Journals | ISI6. Zhejiang Provincial Bureau of Statistics. 2019. Zhejiang statistical yearbook , http://tjj.zj.gov.cn/col/col1525563/index.html (2019, accessed 6 August 2020).
Google Scholar7. The State Council, The People’s Republic of China . Cited Special education promotion plan II (2017–2020), http://gov.cn/xinwen/2017-07/28/content_5214071.htm (2017, accessed 6 August 2020).
Google Scholar8. Jiaxing Disabled Person’s Federation. Measures for the implementation of basic rehabilitation services and subsidy system for disabled children in Zhejiang Province, http://jxdpf.org.cn/news/show.php?itemid=12228 (2017, accessed 6 August 2020).
Google Scholar9. Chen, YY. Economic evaluation of disease burden and prevention strategies of birth defects in China. Shanghai, China: Fudan University Press, 2007.
Google Scholar10. Chiu, MYL, Yang, X, Wong, HT, et al. The mediating effect of affective stigma between face concern and general mental health—the case of Chinese caregivers of children with intellectual disability. Res Dev Disabil 2015; 36C: 437–446.
Google Scholar | Crossref | Medline11. Lin, JD, Hu, J, Yen, CF, et al. Quality of life in caregivers of children and adolescents with intellectual disabilities: use of WHOQOL-brief survey. Res Dev Disabil 2009; 30: 1448–1458.
Google Scholar | Crossref | Medline12. Starrett, D. Foundations of public economics. Cambridge, UK: Cambridge University Press, 1988.
Google Scholar | Crossref13. Redelmeier DA and Heller DN. Time preference in medical decision making and cost-effectiveness analysis. Med Decis Making 1993; 13: 212–217.
Google Scholar14. Liu, GE, Hu, SL, Wu JH, et al. Chinese guide for pharmacoeconomic evaluations. 2020 ed. Beijing, China: China Market Press, 2020.
Google Scholar15. Lemonde, H, Cleary, M, Chakrapani, A. Newborn screening for inborn errors of metabolism. Paediatr Child Health 2015; 25: 103–107.
Google Scholar | Crossref16. Simon, E, Schwarz, M, Roos, J, et al. Evaluation of quality of life and description of the sociodemographic state in adolescent and young adult patients with phenylketonuria (PKU). Health Qual Life Outcomes 2008; 6: 7525.
Google Scholar | Crossref17. Bik-Multanowski, M, Didycz, B, Mozrzymas, R, et al. Quality of life in noncompliant adults with phenylketonuria after resumption of the diet. J Inherit Metab Dis 2008; 31: S415–S418.
Google Scholar | Crossref18. Gassió, R, Campistol, J, Vilaseca, MA, et al. Do adult patients with phenylketonuria improve their quality of life after introduction/resumption of a phenylalanine-restricted diet? Acta Paediatr 2003; 92: 1474–1478.
Google Scholar | Crossref | Medline | ISI19. Bosch, AM, Tybout, W, van Spronsen, FJV, et al. The course of life and quality of life of early and continuously treated dutch patients with phenylketonuria. J Inherit Metab Dis 2007; 30: 29–34.
Google Scholar | Crossref | Medline | ISI20. Hui, J, Tang, NLS, Li, CK, et al. Inherited metabolic diseases in the Southern Chinese population: spectrum of diseases and estimated incidence from recurrent mutations. Pathology 2014; 46: 375–382.
Google Scholar | Crossref | Medline21. Applegarth, DA, Toone, JR, Lowry, RB. Incidence of inborn errors of metabolism in British Columbia, 1969–1996. Pediatrics 2000; 105: e10.
Google Scholar | Crossref | Medline | ISI22. Lindner, M, Gramer, G, Haege, G, et al. Efficacy and outcome of expanded newborn screening for metabolic diseases-report of 10 years from South-West Germany. Orphanet J Rare Dis 2011; 6: 44.
Google Scholar | Crossref | Medline | ISI23. Hassan, FA, El-Mougy, F, Sharaf, SA, et al. Inborn errors of metabolism detectable by tandem mass spectrometry in Egypt: the first newborn screening pilot study. J Med Screen 2016; 23: 124–129.
Google Scholar | SAGE Journals | ISI24. Yunus, ZM, Rahman, SA, Choy, YS, et al. Pilot study of newborn screening of inborn error of metabolism using tandem mass spectrometry in Malaysia: outcome and challenges. J Pediatr Endocrinol Metab 2016; 29: 1031–1039.
Google Scholar | Crossref | Medline25. Yoon, HR, Lee, KR, Kang, S, et al. Screening of newborns and high-risk group of children for inborn metabolic disorders using tandem mass spectrometry in South Korea: a three-year report. Clin Chim Acta 2005; 354: 167–180.
Google Scholar | Crossref | Medline26. Lim, JS, Tan, ES, John, CM, et al. Inborn error of metabolism (IEM) screening in Singapore by electrospray ionization-tandem mass spectrometry (ESI/MS/MS): an 8 year journey from pilot to current program. Mol Genet Metab 2014; 113: 53–61.
Google Scholar | Crossref | Medline | ISI27. Niu, DM, Chien, YH, Chiang, CC, et al. Nationwide survey of extended newborn screening by tandem mass spectrometry in Taiwan. J Inherit Metab Dis 2010; 33: S295–S305.
Google Scholar | Crossref | Medline | ISI28. Lin, Y, Zheng, Q, Zheng, T, et al. Expanded newborn screening for inherited metabolic disorders and genetic characteristics in a Southern Chinese population. Clin Chim Acta 2019; 494: 106–111.
Google Scholar | Crossref | Medline29. Shi, XT, Cai, J, Wang, YY, et al. Newborn screening for inborn errors of metabolism in mainland China: 30 years of experience. JIMD Rep 2012; 6: 79–83.
Google Scholar | Crossref | Medline30. Zhu, F, Xu, J, Dong, L, et al. Analysis of 25243 cases of neonatal genetic metabolic disease screening by tandem mass spectrometry. J Binzhou Med Univ 2015; 38: 300–302.
Google Scholar31. Lu, H, Zheng, J, Yao, Y, et al. A retrospective analysis of tandem mass spectrometry screening for neonatal genetic metabolic diseases in yancheng area. J Birth Health Hered 2016; 24: 83–85.
Google Scholar32. Lin, Y, Huang, XC, Wen, W, et al. Cost benefit analysis of neonatal disease screening in Shenzhen. Chin J Soc Med 2012; 29: 214–216.
Google Scholar33. Xia, XH. Cost benefit analysis of neonatal disease screening in Lianyungang city. Maternal and Child Health Care China 28: 395–397. DOI: 10.7620/zgfybj.j.issn.1001-4411.2013.28.04.
Google Scholar34. Man, XW, Zhang, ZX, Gu, XF, et al. Cost benefit analysis of neonatal disease screening. China Health Econ 2011; 30: 91–93.
Google Scholar35. Zhang, WY, Wan, LX, Zhao, SH, et al. Cost benefit analysis of neonatal congenital hypothyroidism screening in Jilin province. Chin J Control Endem Dis 2013; 28: 443–444.
Google Scholar36. Hsu, CF, Kang, KT, Lee, YL, et al. Cost-effectiveness of expanded newborn screening in Texas. Value Health 2013; 16: 1103–1104.
Google Scholar | Crossref | Medline37. Schoen, EJ, Baker, JC, Colby, CJ, et al. Cost-benefit analysis of universal tandem mass spectrometry for newborn screening. Pediatrics 2002; 110: 781–786.
Google Scholar | Crossref | Medline | ISI38. Huang, XW, Yang, L, Tong, F, et al. Screening for inborn errors of metabolism in high-risk children: a 3-year pilot study in Zhejiang province, China. BMC Pediatr 2012; 12: 18.
Google Scholar | Crossref | Medline39. Korenev, S, Lemonde, H, Cleary, M, et al. Newborn screening for inborn errors of metabolism. Paediatr Child Health 2019; 29: 105–110.
Google Scholar | Crossref